Skip to content
HowShorted

NEOPHOTONICS CORP short interest in 2021

In 2021, NEOPHOTONICS CORP's disclosed short interest ran from 5.03% of shares outstanding on 15 Jan 2021 to 4.29% on 31 Dec 2021, a change of -0.74 percentage points. The year's high was 5.05% on 14 May 2021 and its low 1.98% on 15 Oct 2021, averaging 3.56% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 4.89 days on 15 Jul 2021. Full history: NEOPHOTONICS CORP.

Cite this page
Plain
Wikipedia
BibTeX

By year: 2018 · 2019 · 2020 · 2021 · 2022

Aggregate net short position time series for NEOPHOTONICS CORP in 2021

2021 in figures

Start of year
5.03% (15 Jan 2021)
End of year
4.29% (31 Dec 2021)
Change
-0.74 pp
High
5.05% (14 May 2021)
Low
1.98% (15 Oct 2021)
Average
3.56%
Highest days to cover
4.89 (15 Jul 2021)
SEC filings marked
8

Every report in 2021

NEOPHOTONICS CORP short interest in 2021
SettlementShort interestDays to coverFilings since previous
15 Jan 20215.03%3.88
29 Jan 20213.53%2.11
12 Feb 20213.26%2.76
26 Feb 20213.27%3.1110-K filed, results (8-K)
15 Mar 20214.13%1.53
31 Mar 20214.63%2.38
15 Apr 20213.72%3.92
30 Apr 20213.64%3.9010-Q filed, results (8-K)
14 May 20215.05%2.95
28 May 20214.13%4.15
15 Jun 20213.48%3.46
30 Jun 20212.89%2.30
15 Jul 20212.76%4.89
30 Jul 20213.25%4.85
13 Aug 20212.67%2.3010-Q filed, results (8-K)
31 Aug 20212.99%3.03
15 Sep 20212.52%3.29
30 Sep 20212.05%2.79
15 Oct 20211.98%3.83
29 Oct 20212.12%3.44
15 Nov 20214.69%1.0010-Q filed, results (8-K)
30 Nov 20214.52%2.37
15 Dec 20214.90%2.61
31 Dec 20214.29%2.95

See also: NEOPHOTONICS CORP's full history · most shorted US stocks of 2021 · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.